1-Year Risk-Adjusted Mortality and Costs of Percutaneous Coronary Intervention in the Veterans Health Administration-Reference-Cited by-同舟云学术

1-Year Risk-Adjusted Mortality and Costs of Percutaneous Coronary Intervention in the Veterans Health Administration

Published:2015-01 Issue:3 Volume:65 Page:236-242
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ho P. Michael,O’Donnell Colin I.,Bradley Steven M.,Grunwald Gary K.,Helfrich Christian,Chapko Michael,Liu Chuan-Fen,Maddox Thomas M.,Tsai Thomas T.,Jesse Robert L.,Fihn Stephan D.,Rumsfeld John S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. What is value in health care?;Porter;N Engl J Med,2010

2. Putting the value framework to work;Lee;N Engl J Med,2010

3. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary

4. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association;Go;Circulation,2013

5. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients;Curtis;J Am Coll Cardiol,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based in-hospital mortality prediction models for patients with acute coronary syndrome;The American Journal of Emergency Medicine;2022-03

2. Systemic Immune-Inflammation Index: A Novel Predictor of Coronary Thrombus Burden in Patients with Non-ST Acute Coronary Syndrome;Medicina;2022-01-18

3. Outcomes and regional differences in practice in a worldwide coronary stent registry;Heart;2022-01-10

4. PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN ACUTE CORONARY SYNDROME PATIENTS: A META-ANALYSIS OF HAZARD RATIOS;ACTA MEDICA MEDITERR;2022

5. Development of the Elective Outpatient Percutaneous Coronary Intervention Episode–Based Cost Measure;Circulation: Cardiovascular Quality and Outcomes;2021-03